Ep. 671 Heart Disease and Women's Health in Midlife | Menopause, Cardiovascular Health, Women’s Health
Heart disease remains the leading cause of death among women, yet many women are unaware of their cardiovascular risks or the ways heart disease can present differently in women than in men.
Today, I'm continuing our Metabolic Health Midlife Minute series with an important discussion about women's cardiovascular health. Drawing on my years of experience in cardiology, I explain why women are often diagnosed later, why their symptoms may be overlooked or dismissed, and how decades of underrepresentation in cardiovascular research have contributed to ongoing differences in diagnosis and treatment.
I discuss the symptoms women may experience during a heart attack, the importance of cardiac rehabilitation, and why traditional cardiovascular risk calculators may not provide a complete picture of individual risk. I also explore coronary microvascular disease, the cardiovascular changes associated with perimenopause and menopause, and the importance of understanding markers such as Lp(a), ApoB, and high-sensitivity CRP.
My goal is to help you recognize potential warning signs, ask informed questions, and feel empowered to advocate for appropriate cardiovascular testing and care.
I hope you find today's Midlife Minute informative and empowering, and that you share it with the women in your life.
IN THIS EPISODE, YOU WILL LEARN:
Why heart disease remains the leading cause of death among women
Recognizing heart attack symptoms that may present differently in women than in men
Factors contributing to delayed diagnoses and disparities in cardiovascular treatment
Women's historical underrepresentation in cardiovascular clinical trials and its lasting impact on care
Benefits of cardiac rehabilitation following a heart attack
Important cardiovascular risk markers often overlooked by traditional risk calculators, including Lp(a), ApoB, and high-sensitivity CRP
How coronary microvascular disease can cause symptoms even when major coronary arteries appear clear
Understanding why women's cardiac symptoms are sometimes dismissed as stress or anxiety
Cardiovascular changes associated with perimenopause and menopause
Reasons to prioritize heart disease prevention earlier in life
Using coronary artery calcium scoring and additional testing to assess cardiovascular risk
Strategies for advocating for further evaluation when cardiac symptoms persist despite normal initial test results
Connect with Cynthia Thurlow
Visit Cynthia's website.
Check out the Everyday Wellness Podcast on Instagram.
Follow Cynthia on X, Instagram, and LinkedIn.
Submit your questions to [email protected].
Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.
Purchase Cynthia's book, The Menopause Gut.
Purchase Cynthia's book, Intermittent Fasting Transformation.
Explore The Midlife Pause Supplement Line.
For more information about Cynthia's upcoming retreat, visit Cynthia's website and click the Events tab.
Research References:
Peters SA, Huxley RR, Woodward M. Diabetes as Risk Factor for Incident Coronary Heart Disease in Women Compared With Men: A Systematic Review and Meta-Analysis of 64 Cohorts Including 858,507 Individuals and 28,203 Coronary Events. Diabetologia. 2014.
Huxley RR, Woodward M. Cigarette Smoking as a Risk Factor for Coronary Heart Disease in Women Compared With Men: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Lancet. 2011.
Liu T, Vonen HD, Henao R, et al. Lifetime Adverse Pregnancy Outcome History and Cardiovascular Risk. Hypertension. 2026.
Okoth K, Chandan JS, Marshall T, et al. Association Between the Reproductive Health of Young Women and Cardiovascular Disease in Later Life: Umbrella Review. BMJ. 2020.
Kwak S, Park CS, Park Y, et al. Hypertensive Disorders of Pregnancy Subtypes and Long-Term Cardiovascular Risk. JAMA Intern Med. 2026.
Tay CT, Mousa A, Vyas A, et al. 2023 International Evidence-Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta-Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome. J Am Heart Assoc. 2024.
Cho L, Davis M, Elgendy I, et al. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020.
Bello N, Meyers KJ, Workman J, Hartley L, McMahon M. Cardiovascular Events and Risk in Patients With Systemic Lupus Erythematosus: Systematic Literature Review and Meta-Analysis. Lupus. 2023.
Hansildaar R, Vedder D, Baniaamam M, et al. Cardiovascular Risk in Inflammatory Arthritis: Rheumatoid Arthritis and Gout. Lancet Rheumatol. 2021.
Conrad N, Verbeke G, Molenberghs G, et al. Autoimmune Diseases and Cardiovascular Risk: A Population-Based Study on 19 Autoimmune Diseases and 12 Cardiovascular Diseases in 22 Million Individuals in the UK. Lancet. 2022.
Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. N Engl J Med. 2024.
Shah AS, Griffiths M, Lee KK, et al. High Sensitivity Cardiac Troponin and the Under-Diagnosis of Myocardial Infarction in Women: Prospective Cohort Study. BMJ. 2015.
Festa A, D’Agostino R, Hanley AJ, et al. Differences in Insulin Resistance in Nondiabetic Subjects With Isolated Impaired Glucose Tolerance or Isolated Impaired Fasting Glucose. Diabetes. 2004.
Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D. Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol. 2014.
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women. JAMA. 2007.